Regional Bioavailability of ABT-333 in Healthy Subjects (QBR115332)

• Research type

  Research Study

• Full title

  A Phase I, Open-Label Study to Investigate the Regional Bioavailability of ABT-333 when Delivered to Different Sites within the Gastrointestinal Tract in Healthy Subjects

• IRAS ID

  137296

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  AbbVie Deutschland GmbH & Co KG

• Eudract number

  2013-003161-34

• REC name

  HSC REC A

• REC reference

  13/NI/0134

• Date of REC Opinion

  17 Sep 2013

• REC opinion

  Further Information Favourable Opinion